The cytotoxicity reaction of murine CD8 T lymphocytes has been found to be strongly inhibited by nanomolar concentrations of hypericin, a lipophilic dianthraquinone with photodynamic properties. Cytotoxic T lymphocyte (CTL)-induced target cell apoptosis, as well as exocytosis of cytolytic granules from these cells, were ablated by hypericin, administered at the onset of the reaction, without affecting CTL viability. The inhibition of cytolysis occurred without the light irradiation which is essential for photosensitization. The findings suggest that the action of hypericin targets the effector CTL; however, apoptosis induced in murine L-cells with recombinant tumor necrosis factor (TNF)-α was also prevented by hypericin. Since hypericin is a known inhibitor of protein kinase C, MAP kinase and at least one other tyrosine kinase, this inhibitory activity could play a role in the down-modulation of CTL-induced cytotoxicity. Furthermore, our studies show that the action of hypericin induces rapid dephosphorylation of phospholipids associated with low-density membranes in CTL, but not with membranes of the cytotoxic granules. The ability of hypericin to interfere with cytotoxicity may render it useful in the treatment of T cell-mediated diseases.
Introduction
Perihydroxylated polycyclic quinones are the focus of increaslight irradiation (10) . Clinical efficacy studies are currently ongoing to evaluate this photosensitizer against cutaneous ing interest due to their broad range of biological activities. One compound in this group, hypericin ( Fig. 1) , is a photo-T cell lymphoma. The physico-chemical properties of hypericin are complex. dynamic agent which we have initially found to be virucidal to retroviruses (1, 2) as well as to other lipid enveloped viruses
In the presence of light hypericin generates singlet oxygen (11, 12) , free radicals (12, 13) and under some circumstances (3). Hypericin also acts as an irreversible light-dependent inhibitor of protein kinase C (PKC) (4) and MAP kinase (5) , also semiquinones (14) . In addition, effects such as growth inhibition of malignant glioma cells in culture are independent but has negligible effects on casein kinase I and II or on protein kinase A (5). Inhibition of epidermal growth factor of light (7); the virucidal activity of hypericin, while strongly enhanced by light (15) , has also been documented in the receptor tyrosine kinase has also been suggested, affecting the enzyme in its membrane-associated native form, but dark against murine cytomegalovirus (16) . The dark effects do not necessarily reflect a different mode of action and not when solubilized (6) . These inhibitory activities of cell proliferation signal transduction pathways prompted the clinappear to be due to a low red/ox potential, enabling hypericin to act as an electron scavenger from physiological transfer ical evaluation of hypericin as an antitumoral agent inhibiting the growth of malignant glioma (7, 8) and pituitary adenoma reactions (17) .
Here we report that hypericin effectively inhibits the cytotumors (9) . The two tumors rely on PKC signaling for cell proliferation (7, 8) . Recently, the phototoxic properties of hypertoxicity reaction of sensitized cytotoxic T lymphocytes (CTL) in vitro. This effect was associated with dephosphorylation of icin have also been addressed and found to be useful in the photodynamic therapy of tumors, in treatments coupled with phospholipids in the low-density membrane fractions of CTL. We suggest that hypericin may be useful in the treatment of ium bromide to formasan in mitochondria of viable cells (19) . MTT was added to cells cultured in 96-well plates (in autoimmune diseases such as psoriasis and possibly also various forms of organ transplant rejection, in the pathogentriplicates) 48 h after induction of apoptosis. The cultures were incubated for 4 h at 37°C and analyzed in an ELISA esis of which cytotoxic effects of T cells play a role.
reader at 560 nm. Corrections for non-specific optical absorption by MTT were made in medium with or without hypericin Methods at each corresponding dose level. The optical density of formasan generated by untreated cell cultures (OD control ) was Preparation of hypericin defined as 1 MTT unit. The number of MTT units in culture Hypericin (10,11-dimethyl-1,3,4,6,8,13-hexahydroxy-naphthosamples undergoing treatments was calculated as the ratio dianthrone) was synthesized by self-condensation of emodin (OD sample -OD blank /OD control ). anthrone (18) . Emodin anthrone (Societa Inverni della Beffa, Milan, Italy) was dissolved in pyridine and heated with piperidDevelopment of CTL clones sensitized against class I or ine, pyridine-N-oxide and catalytic amounts of FeSO 4 (Aldrich class II histocompatibility complex determinants Chemicals), resulting in the formation of protohypericin.
Two sets of CTL clones were developed. Anti-H-2 d CTL Photoactivated ring closing was obtained by irradiation of generated in spleen and lymph node cells from C3H (H-2 b ) protohypericin with visible light to yield free hypericin, which mice sensitized against (C3HϫBALB/c)F 1 , (H-2 bd ) stimulator was crystallized from pyridine, resulting in a hypericincells; and anti-class II I-A q I-E q CTL developed from B10.AQR pyridine complex. This complex was heated to 160°C for 2 h cells sensitized against B10.T(6R) cells (H-2 K q I-A q I-E q D d ). in high vacuum. The resulting free hypericin was dissolved From each group, 4ϫ10 6 responder cells were sensitized in methanol and converted to a monosodium salt by adding against 2ϫ10 7 X-irradiated (1500 rad) stimulator spleen cells aqueous NaHCO 3 , precipitation with hexane and crystallizafor 5 days. Re-stimulations with 5ϫ10 6 freshly prepared tion from methanol. Hypericin was purified to 98.7% by irradiated spleen cells were at 5 day intervals and at day 15 chromatographies on silica gel (Merck 60; 70-230 mesh) the growth medium was supplemented with 100 U/ml of rILeluted with methanol:EtOAc 2:1 and 1% aqueous NaH 2 PO 4 .
2 (Cetus, Norwalk, CT). On day 14 the cells were cloned by For the bioassays hypericin was dissolved to 4 mM in 70% limiting dilution in 96-well microplates on 5ϫ10 4 irradiated aqueous ethanol. Subsequent dilutions were made in cell stimulator feeder cells in medium DMEM, 15% fetal bovine culture media limiting the final EtOH concentration to 1%. serum, 100 U/ml penicillin and 100 µg/ml streptomycin. rIL-2 at 100 U/ml was added after 5 days and subsequently Chemicals, isotopes, reagents and antisera reduced to a maintenance dose of 75 U/ml. Isolated colonies Recombinant tumor necrosis factor (TNF)-α was a gift from were subcloned and expanded in 50 ml tissue culture flasks. Dr Joseph Lotem (Department of Molecular Genetics, WeizCloned cells were stained with fluorescein-labeled anti-CD4 mann Institute, Rehovot Israel). Na 51 CrO 4 and Na 2 H 32 PO 4 and -CD8 antibodies (PharMingen, San Diego, CA), and from New England Nuclear Du-Pont (Wilmington, DE). Phyanalyzed by FACS. The different clones were screened for tohemagglutinin (PHA)-P was purchased from Sigma (St cytotoxic activity against 51 Cr-labeled appropriate targets and Louis, MO).
the clones which were most cytotoxic were selected for experimentation.
Cell lines
Murine P815 cells were grown in DMEM supplemented with Cytotoxicity assays 10% heat-inactivated FCS, 100 mM L-glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin. L-cells were grown in
The cytotoxic activities of the CD8 ϩ T cell clones were examined in 4 h 51 Cr-release assays: C3H CTL against P815 RPMI-1640 supplemented with 10% heat-inactivated FCS, glutamine and antibiotics. All cell lines were cultured in a leukemia cells (H-2 d ) targets and the other CTL set against PHA stimulated primary spleen cells (PHA blasts) derived humidified 5% CO 2 /95% air atmosphere at 37°C. from the corresponding stimulator mice strains. Assays were Cell viability run in triplicates in 96-well round-bottom microplates. From the time hypericin was added to the cultures the microplates Cell viability was monitored by the MTT assay, which measures reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolwere maintained in relative darkness (hood lights off), to prevent light-induced phototoxicity due to the photodynamic cells were dispersed 4ϫ10 6 /tube in normal DMEM supplemented with 10% FCS and treated with 10 µM hypericin for properties of hypericin. The total exposure to light was monitored carefully and kept Ͻ0.05 J/cm 2 . Experiments were different time intervals. Following incubation the cells were disrupted in hypotonic lysis buffer (5 mM Tris pH 7.5, 5 mM repeated at least 3 times. Percent specific cytotoxicity was calculated according to the formula: (sample 51 Cr releaseMgCl 2 , 1 mM EGTA and 1 mM dithiothreitol) and homogenized in a loosely fitted Dounce homogenizer. Complete Protease spontaneous release)/(maximal release -spontaneous release)ϫ100.
Inhibitor Cocktail (40 µl/ml; Boehringer Mannheim) was added, the cell lysates brought to 30% in sucrose, loaded onto Exocytosis of granules from CTL discontinuous 40, 45 and 50% sucrose gradients, and spun at 100,000 g for 30 min. Cytosol and all interfaces were The specific discharge of N-α-benzyloxycarbonyl-L-lysine thiobenzyl ester (BLT) esterase activity into the reaction collected, the sucrose removed by dialysis against Buffer A (10 mM Tris, pH 7.5, 5 mM MgCl 2 and 1 mM EGTA), and the medium of cytotoxicity assays, was used to monitor exocytosis of granzyme-containing granules from CTL. CTL-conditioned, various separated membrane fractions pelleted at 20,000 g for 30 min. All fractions were solubilized in buffer A containing cell-free reaction media were collected 2 h after initiation of cytolysis. Aliquots of 20 µl were incubated with 180 µl enzyme 1% Triton X-100 and separated on 14% SDS-PAGE. The gels were dried and developed for autoradiography. substrate, which consisted of 30 µl of 20 mM N-benzyloxycarbonyl-L-lysine thiobenzyl ester (Calbiochem, San Diego CA), dissolved in 0.1 M Tris-HCl (pH 8), mixed shortly before the Results assay with 30 µl of 20 mM DNTB (Pierce, Rockford, IL) in 3 ml Tris buffer. The assay was run for 30 min at room
The effect of hypericin on CTL-mediated target cell apoptosis temperature (20) and substrate hydrolysis analyzed at 405
The two cytotoxic CD8 T cell clones which were developed, nm in an ELISA plate reader. Specific granule exocytosis was against H-2 d , class I and MHC class II I-A q I-E q antigens were calculated as the difference between BLT esterase activity analyzed for the effects of hypericin on their ability to induce released into the reaction medium by CTL activated with P815 target cell apoptosis. Different doses of hypericin were added targets and BLT esterase activity released spontaneously by at the beginning of the cytotoxicity reactions with all sub-CTL. Only experiments in which spontaneous BLT release sequent steps performed under controlled lighting conditions was Ͻ10% were considered.
(
see Methods). Figure 2(A) shows the effect of hypericin on Determination of percentage of apoptotic cells
4 h 51 Cr-release assays of C3H CTL reacted against P815 targets. Figure 2 (B) relates to the effect of hypericin on the Percentage of apoptotic cells, characterized by nuclear fragactivity of B10.AQR CTL reacted against class II I-A q I-E qmentation, chromatin condensation and DNA internucleosoexpressing PHA blasts in the presence of hypericin. Hypericin mal digestion, was determined microscopically using the was found to inhibit target cell apoptosis by sensitized CTL TUNEL POD method of Boehringer Mannheim (Mannheim, in both systems. Doses of 0.4 and 1 µM hypericin effectively Germany) (in which TdT-added terminal fluoresceinated inhibited 50-60 and ഛ90% of the cytotoxic activity of the nucleotide is visualized with peroxidase conjugated anticorresponding untreated cells respectively in most analyses. fluorescein). One hundred cells in four preparations (total of
The strong inhibitory activity of target cell apoptosis by 400 cells) were counted by two individuals, independently.
hypericin appears, quite likely, to be a light-independent The data are given as the mean and SD calculated per process. four events.
The effect of hypericin on cytotoxic granule exocytosis from Induction of phototoxicity CTL in a cytotoxicity reaction Photodynamic toxicity is the damage inflicted upon target cells
The release of granules from CTL, that contain granzymes by a photosensitizer in the presence of light. Photosensitization and pore-forming perforins (21,22), is another functional arm generates singlet oxygen and, in the case of hypericin, of the cytotoxicity reaction. We examined whether hypericin additional reactive oxygen species such as free radicals. also affected granule exocytosis from effector CTL. CD8 cells Light irradiation was performed from two parallel 40 W fluorsensitized against H-2 d were stimulated with P815 targets to escent tubes placed at a fixed distance of 16 cm and induce granule exocytosis. The cell-free reaction media were measured to emit an incidence of 4 mW/cm of polychromatic collected after 2 h and their granule contents analyzed in the white light. Light intensities were quantitated using the IL BLT esterase assay. The results are shown in Fig. 3 . A 1350 radiometer/photometer from International Light hypericin dose-dependent inhibition of granule exocytosis (Newburryport, MA).
from CTL was observed that was linear up to a hypericin Radiolabeling and subcellular fractionation of CTL concentration of 1 µM and reached baseline levels at 2 µM. CTL (2ϫ10 7 ) were washed twice with phosphate-deficient Hypericin toxicity to CTL and the role of light in the inhibition DMEM (Gibco, Grand Island, NY) and incubated for phosof CTL-mediated apoptosis phate starvation in 2 ml of this medium supplemented with 2% FSC (Hyclone, Logan, UT) for 1 h. The cells were spiked
The possibility that the inhibition of cytolysis by hypericin stems from toxicity to CTL has also been addressed. The with 50 µCi Na 2 H 32 PO 4 and incubated at 37°C, 5% CO 2 for 90 min. Labeling was terminated with excess PBS and free T cell clones were exposed to different concentrations of hypericin for 4 h under the same conditions in which 51 Cr Na 2 H 32 PO 4 was removed by washing 3 times with PBS. The µM was added, the cultures spun gently at 500 g for 2 min, and incubated at 37°C, 5% CO 2 for 2 h. The cell-free reaction media were collected and assayed for BLT esterase activity. Another set of controls included supernatants from samples assayed for cytotoxicity in the absence of hypericin to which the drug was added prior to the BLT esterase assay to monitor for possible interference with the assay by hypericin. Open circles refer to baseline levels of BLT esterase released from unstimulated, sensitized CD8 cells plated in the absence of target cells. Results are given Ϯ SD. mediated or enhanced by light, the possible role of light in the arrest of CTL-induced cytotoxicity by hypericin was examined. Direct analyses of the effects of hypericin in (Fig. 5) . The total dose of ambient light during benchwork was maintained ഛ0.03 J/cm 2 .
The effects of hypericin on target cell apoptosis induced by release from target cells was inhibited. Lighting was controlled
TNF-α receptor ligation keeping hood lights shut off. Cell viability was analyzed after 4 h by Trypan blue exclusion. CTL viability was unimpaired Hypericin interacts with cell membrane phospholipids (23) and can modulate some of their functions including transducby the treatment with hypericin at doses which prevented target cell apoptosis and granule exocytosis (data not shown).
tion of signals generated at the cell surface (5,6). Since many of the apoptosis-inducing signals are initiated at the cell Toxicity to CTL appears unlikely to be the cause for the observed inhibition of CTL-mediated target cell apoptosis by surface, the possible effects that treatment with hypericin can have on cells triggered to undergo apoptosis were studied hypericin. Figure 4 shows that inhibition of both arms of the cytotoxicity reaction, 51 Cr release and granule exocytosis using murine L-cells, which are highly susceptible to TNF-α. L-cells exposed to different concentrations of hypericin were results from the action of hypericin on CTL and not on the target cells.
then induced to undergo apoptosis with 100 U/ml TNF-α. Cell viability was analyzed after 48 h and compared to control Since many of the biological activities of hypericin are TNF-α was then applied at each of three doses: 50, 500 and 5000 U/ml. The cells were cultured at 37°C, 5% CO 2 for an additional 48 h and their viability was then assessed by the MTT assay. Data are averages of triplicate wells Ϯ SD from a representative experiment of four that were performed. cells not exposed to TNF-α, using the MTT assay. The results (Fig. 6) show an effective hypericin dose-dependent protection of L-cells from TNF-α-induced apoptosis. Cell viability was preserved at near control levels by 10 µM hypericin. The potency of the protective effect was estimated (Fig. 7) dose-related manner. The TNF-α-activated apoptotic pathway appears to also be affected by hypericin, unrelated to the inhibitory effects of this molecule on CTL.
Dephosphorylation of phospholipids on CTL low-density membranes by hypericin
Numerous studies that examined possible subcellular targets for the action of hypericin on CTL focused on possible effects of this molecule on protein phosphorylation or dephosphorylation. These were driven by the recognition that, on one hand, hypericin acts as inhibitor of numerous classes of cellular kinases and, on the other, that photosensitization activates phospholipases in mouse lymphoma cells (24). The most noticeable effects of hypericin were on phospholipids of the low-density membrane fraction. CTL prelabeled with [ 32 P]orthophosphate were treated with 10 µM hypericin for 0.5, 1 and 1.5 h. Unincorporated isotope was removed, the cells lysed by hypotonic shock and fractionated on sucrose-density gradients into cytosol, and low-density membranes (30/40% interphase which contains the endoplasmic reticulum and surface membranes) and higher-density membranes recovered from the 40/45 and 45/50% interphases (25), as described in Methods. The different isolated fractions were separated on SDS-PAGE and developed for autoradiography. Figure 8(a) , shows that the treatment with hypericin induced a rapid dephosphorylation of phospholipids in the low-density membrane fractions of CTL which migrated close to the gel front. The dephosphorylation occurred within short incubation periods with 10 µM hypericin. The phospholipid nature of these bands was confirmed by extraction with chloroform:methanol 1:2, which eliminated the lipid bands in subsequent runs, and by thin layer chromatography of the solvent moiety on silica gel plates developed with CHCl 3 :MeOH:NH 4 OH:H 2 O (26:15:3:1 v/v) (data not shown). Similar, low-density membrane dephosphorylation patterns were observed following 3 h treatments with 5 and 15 µM hypericin (Fig. 8b) . The bands were excised from the gels and the radioactivity determined in a γ-counter showing 64 and 76% inhibition of 32 P incorporated into the phospholipid band by treatments with 5 and 15 µM hypericin respectively. There was no evidence for effects on higher-density membrane fractions which harbored BLT hydrolytic activity (Fig. 9) , suggesting that the dephosphorylating activity of hypericin The action is rapid and it was sufficient to administer hypericin at the beginning of cytotoxicity in order to effectively inhibit the reaction. It may be noteworthy that hypericin also inhibits human NK cell-mediated K-562 target cell lysis in a similar release from target cells was suppressed and granule exocytosis from T cells was ablated in a hypericin dosemanner (data not shown and will be discussed elsewhere). CTL appear to be the affected cells as evident from experidependent manner. The effect could result either from the action of hypericin on each of the two pathways or, alternatments in which CD8 T cells or target cells were each treated separately with hypericin (Fig. 4) . Association of the molecule ively, by inhibiting the activation of the lytic pathway upstream to the divergence into the two arms of the response. with CTL inhibited cytotoxicity at two levels: 51 Cr isotope down of membrane phosphoinositides and increased aracidonic acid release. Phospholipase A 2 has also been implicated in this phospholipid breakdown (24). Phospholipase D1, which localizes in resting cells to secretory granules and lysosomes, has been shown to translocate to the plasma membrane upon cellular stimulation (36). Modulation of phospholipase D1 could also be associated with the observed inhibition of granule exocytosis by hypericin. Although phospholipase activation by the phthalocyanine derivative was light dependent and the dephosphorylation of CTL low-density membrane fractions by hypericin, described here, occurred under minimal lighting conditions, the underlying mechanisms may be similar. A role for red/ox reactions cannot be entirely excluded. Hypericin is known to elicit photodynamic reactions in the dark, most likely due to its relatively low red/ox potential which, as mentioned above, enables electron scavenging for its excitation (17) .
While treatment of target cells with hypericin in CTLmediated cytotoxicity showed negligible effect on their levels phases of the apoptotic cascade in dying cells appear to also be affected. For example, hypericin was noted to effectively protect murine L-cells from apoptosis induced by quite high The complexity of the cytotoxicity reaction offers many doses of TNF-α, maintaining L-cells viability in the presence target sites for inhibition by hypericin: adhesion molecules of TNF-α. The propensity of hypericin to act in association (26, 27) and lymphocyte function-associated antigens (28, 29) with membranes may imply that TNF type 1 receptor crossare involved in effector-target cell interactions, with engagelinking (37) is inhibited at the target cell level. ment of the TCR and activation of the lytic pathway. The
Hypericin is currently being evaluated in clinical trials as outcome is presentation of Fas ligand on CTL followed an anticancer agent, based on its signal transduction inhibitory by secretion of granules containing pore-forming perforin, properties of cell proliferation. The current findings, which proteolytic granzymes (21,30-31) and the cytotoxic molecule demonstrate interference with cell-mediated cytotoxicity withgranulysin (32). Potential targets for CTL lytic pathway deacout depleting the organism of effector cells, suggest the tivation by hypericin may be phosphoproteins which particippossible utilization of hypericin to treat pathological states ate in transduction of signals that culminate in lytic pathway generated by the cytotoxic effects of T cells. Diseases such activation and granule exocytosis. Their phosphorylation can as psoriasis, aspects of graft versus host disease, juvenile be inhibited by hypericin, a well-documented potent inhibitor diabetes and others are potential indications. Clinical sympof PKC (4, 5) , epidermal growth factor receptor tyrosine kinase toms of graft versus host disease, which we induced in mice, (6) and MAP kinase (4) . In CD8 ϩ CTL clones, Fas ligand were improved by repeated dosing of the animals with induction by engagement of TCR is inhibited by herbimycin hypericin (unpublished data). Hypocrellins, obtained from the and by the more general protein tyrosine kinase (PTK) inhibitor fungus Hypocrella bambuase, which are natural quinones genistein and ionomycin (33) . In NK cells, protein tyrosine related to hypericin in structure, physico-chemical and photophosphorylation has been suggested to be required for dynamic properties, are being used in China to treat psoriasis cytotoxicity and killing is also inhibited with the PTK inhibitor (38, 39) . This activity of hypocrellins provides an additional herbimycin (34). Numerous tyrosine kinases, p56 lck , p59 fyn indirect incentive to the clinical development of hypericin. and the syk family kinase ZAP-70, are phosphorylated during NK cell activation (35) . Their role in the cytolytic responses is unclear, however, since knockout mice deficient in these Acknowledgements genes exhibit unimpaired cytolytic responses. It appears unlikely that their inhibition by hypericin accounts for the The most noticeable change that we observed in CTL after hypericin treatment is the rapid phospholipid dephosphorylation that is confined to the low-density membrane fractions and Abbreviations becomes evident within 0.5-1.5 h after addition of hypericin to 
